DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

ACTAVIS (NYSE: ACT)



company name or ticker

Does This Dividend Stock Belong in Your Portfolio in 2015?

Teva Pharmaceutical Industries is a favorite name among income investors. With steep headwinds facing the company in 2015, though, its dividend might be at risk. Here's what investors need to know.

Alexion Seeks FDA Approval for its Hypophosphatasia Drug - Analyst Blog

VUG, CELG, BIIB, ACT: Large Inflows Detected at ETF

Teva's Granix Label Expanded to Include Self-Administration - Analyst Blog

Gilead/J&J Expand TAF-based HIV Drugs Related Agreement - Analyst Blog

The Allergan Acquisition Is A Game-Changer For Actavis: Stock Could Double In Five Years

Billionaires Are Buying More of These 3 Stocks

Hedge funds have been buying more and more of these three stocks in recent months.

Actavis' Alzheimer's Drug Approved; Bystolic Gets CRL - Analyst Blog

Actavis' Alzheimer's Drug Approved; Bystolic Gets CRL - Analyst Blog

Health Care Sector Update for 12/26/2014: NVS, HZNP, ACT

FDA denies approval for Actavis hypertension treatment

See More Articles...